<info type="GeneOrGeneProduct">Vitamin D-binding protein</info> gene polymorphism association with <info type="GeneOrGeneProduct">IA-2</info> autoantibodies in <info type="DiseaseOrPhenotypicFeature">type 1 diabetes</info>.

BACKGROUND: <info type="GeneOrGeneProduct">Vitamin D-binding protein</info> (<info type="GeneOrGeneProduct">DBP</info>) is the main systemic transporter of <info type="ChemicalEntity">1.25(OH)2D3</info> and is essential for its cellular endocytosis. There are two known polymorphisms in exon 11 of the <info type="GeneOrGeneProduct">DBP</info> gene resulting in amino acid variants: <info type="SequenceVariant">GAT-->GAG</info> substitution replaces <info type="GeneOrGeneProduct">aspartic acid</info> by <info type="GeneOrGeneProduct">glutamic acid</info> in codon 416; and <info type="SequenceVariant">ACG-->AAG</info> substitution in codon 420 leads to an exchange of <info type="GeneOrGeneProduct">threonine</info> for <info type="GeneOrGeneProduct">lysine</info>. These <info type="GeneOrGeneProduct">DBP</info> variants lead to differences in the affinity for <info type="ChemicalEntity">1.25(OH)2D3</info>. Correlations between <info type="GeneOrGeneProduct">DBP</info> alleles and <info type="DiseaseOrPhenotypicFeature">type 1 diabetes</info> have been described in different populations. Therefore, we investigated the <info type="SequenceVariant">polymorphism in codon 416</info> of the <info type="GeneOrGeneProduct">DBP</info> gene for an association with autoimmune markers of <info type="DiseaseOrPhenotypicFeature">type 1 diabetes</info>. DESIGN AND METHODS: The present analysis was a case control study. 110 patients, 68 controls, and 115 first-degree relatives were genotyped for the <info type="GeneOrGeneProduct">DBP</info> polymorphism in codon 416. <info type="GeneOrGeneProduct">DNA</info> typing of <info type="GeneOrGeneProduct">DBP</info> locus was performed by the <info type="GeneOrGeneProduct">PCR</info>-<info type="GeneOrGeneProduct">restriction fragment length polymorphism</info> method (RFLP). RESULTS: The frequencies of the <info type="GeneOrGeneProduct">Asp/Glu</info> and <info type="GeneOrGeneProduct">Glu/Glu</info> were significantly increased in diabetic subjects with detectable <info type="GeneOrGeneProduct">IA-2</info> antibodies (P < 0.01). On the contrary, the <info type="GeneOrGeneProduct">DBP Glu</info>-containing genotype was not accompanied by differences in the prevalence of <info type="GeneOrGeneProduct">GAD65</info> antibodies. These finding supports a role of the <info type="ChemicalEntity">vitamin D</info> endocrine system in the autoimmune process of <info type="DiseaseOrPhenotypicFeature">type 1 diabetes</info>.